» Articles » PMID: 17218915

Long-term Outcomes of Vitrectomy with or Without Arteriovenous Sheathotomy in Branch Retinal Vein Occlusion

Overview
Journal Retina
Date 2007 Jan 16
PMID 17218915
Citations 35
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: To evaluate the long-term effect of vitrectomy with or without arteriovenous sheathotomy for macular edema secondary to branch retinal vein occlusion (BRVO).

Methods: The study was a prospective, randomized, comparative, interventional case series of 36 patients (36 eyes) who underwent pars plana vitrectomy with or without arteriovenous sheathotomy for macular edema due to BRVO of <or=8 weeks' duration of symptoms. Eighteen eyes with arteriovenous sheathotomy (sheathotomy group) were compared with 18 eyes without sheathotomy (vitrectomy group). Main outcomes measures were best-corrected visual acuity and central foveal thickness as evaluated by optical coherence tomography.

Results: Baseline demographic characteristics of the groups were similar. Postoperative follow-up period ranged from 12 months to 45 months (31 months). Median best-corrected visual acuity significantly improved from 0.4 at baseline to 1.0 at the final visit in both groups, and there was no significant difference in best-corrected visual acuity at any postoperative period between the groups. Of 16 patients with duration of symptoms of <4 weeks, those with arteriovenous sheathotomy had a tendency toward better visual outcomes than those without arteriovenous sheathotomy (P = 0.064). The central foveal thickness also significantly decreased after surgery in both groups, but the differences were not significant for the two groups at each time point. No patients had severe intraoperative and/or postoperative complications.

Conclusions: Our findings suggest that vitrectomy with or without arteriovenous sheathotomy may improve the long-term functional and tomographic outcomes for patients with macular edema secondary to BRVO. Although additional arteriovenous sheathotomy did not lead to a distinct functional benefit in this series, early surgical intervention may result in better visual outcomes.

Citing Articles

Ocular microcirculation changes, measured with laser speckle flowgraphy and optical coherence tomography angiography, in branch retinal vein occlusion with macular edema treated by ranibizumab.

Asano T, Kunikata H, Yasuda M, Nishiguchi K, Abe T, Nakazawa T Int Ophthalmol. 2020; 41(1):151-162.

PMID: 32894391 DOI: 10.1007/s10792-020-01562-7.


A systematic review of real-world evidence of the management of macular oedema secondary to branch retinal vein occlusion.

Ang J, Ah-Moye S, Kim L, Nguyen V, Hunt A, Barthelmes D Eye (Lond). 2020; 34(10):1770-1796.

PMID: 32313172 PMC: 7608462. DOI: 10.1038/s41433-020-0861-9.


Angiographic Risk Features of Branch Retinal Vein Occlusion Onset as Determined by Optical Coherence Tomography Angiography.

Kogo T, Muraoka Y, Iida Y, Ooto S, Murakami T, Kadomoto S Invest Ophthalmol Vis Sci. 2020; 61(2):8.

PMID: 32031580 PMC: 7324438. DOI: 10.1167/iovs.61.2.8.


Arteriovenous crossing associated with branch retinal vein occlusion.

Muraoka Y, Tsujikawa A Jpn J Ophthalmol. 2019; 63(5):353-364.

PMID: 31396750 DOI: 10.1007/s10384-019-00676-5.


Vitrectomy for macular edema due to retinal vein occlusion.

Kumagai K, Ogino N, Fukami M, Furukawa M Clin Ophthalmol. 2019; 13:969-984.

PMID: 31354231 PMC: 6580136. DOI: 10.2147/OPTH.S203212.